08-09
Sat
08:00-10:00
分会场12：二层A206
英文会场3
08:00-08:12
AQP4水交换磁共振时空定量胶质瘤细胞增殖的机制和应用
In vivo spatiotemporal mapping of proliferation activity in gliomas via AQP4 water-exchange dynamic contrast-enhanced MRI
08:12-08:20
少突胶质细胞分泌ERBB3与肿瘤细胞相互驯化促进肺癌脑转移的机制研究
Oligodendrocyte-secreted ERBB3 mediates the competitive uptake of copper ions by tumor cells to promote brain metastasis in lung cancer
08:20-08:28
综合分析揭示胶质瘤中肿瘤相关中性粒细胞的异质性
Integrated analysis to reveal heterogeneity of tumor-associated neutrophils in glioma
08:28-08:36
2021年WHO中枢神经系统肿瘤分类下EGFR扩增在弥漫性胶质瘤中临床应用的真实世界研究
Clinical roles of EGFR amplification in diffuse gliomas: A real-world study using the 2021 WHO classification of CNS tumors
08:36-08:44
靶向SSTR2的嵌合抗原受体T细胞疗法对脑膜瘤的疗效研究
Adapter chimeric antigen receptor T cell therapy targeting SSTR2 in meningioma.
08:44-08:52
脑脊液TERT启动子突变在胶质瘤术后动态监测中的应用
Cerebrospinal Fluid-Derived TERT Promoter Mutations in Postoperative Surveillance of Glioma: a Prospective Study
08:52-09:00
垂体腺瘤的染色质可及性图谱揭示其特异性改变并区分库欣病
Chromatin Accessibility Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiate Cushing's Disease
09:00-09:12
PATZ1融合的中枢神经系统肿瘤为新增独立脑肿瘤类型：基于甲基化谱、临床病理分析及其与外周对应肿瘤的比较研究
Defining PATZ1-Fused CNS Tumors as a Distinct Entity: Insights from Methylation Landscapes, Clinicopathological Correlation, and Comparative Survival with Peripheral Counterparts
09:12-09:20
Spatial Distribution of Meningiomas: A Magnetic Resonance Image Atlas
Spatial Distribution of Meningiomas: A Magnetic Resonance Image Atlas
09:20-09:28
单中心双灶性垂体腺瘤的临床总结及系统回顾
Results of double pituitary adenomas in a single center and systematic review of the literature
09:28-09:36
在脑肿瘤研究中架起放射学和组织病理学的桥梁：用连续时间随机游走模型绘制肿瘤微环境
Bridging Radiology and Histopathology in Brain Tumor Research: Mapping Tumor Microenvironment with the Continuous-Time Random Walk Model
09:36-09:44
PROTAC EPIC-0726通过K63/K48泛素化依赖的ERK/AKT抑制和p21稳定作用激活PEAKS进而增强替莫唑胺在胶质母细胞瘤中的疗效
PEAKS activation by PROTAC EPIC-0726 potentiates temozolomide in glioblastoma via K63/K48 ubiquitination-dependent ERK/AKT suppression and p21 stabilization
09:44-09:52
Anlotinib in combination with dose-intense temozolomide for the recurrent or progressive glioblastoma after STUPP regimen.
Anlotinib in combination with dose-intense temozolomide for the recurrent or progressive glioblastoma after STUPP regimen.
09:52-10:00
应用年龄分层模型预测脑肿瘤患者活检后出血风险
Predicting Post-Biopsy Hemorrhage in Brain Tumor Patients with Age-Stratified Models
